Blue Edge Capital’s Merck MRK Stock Holding History

Blue Edge Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.27M	Buy	18,891 +837	+5%	+$96.6K	0.3%	60
2025 Q4	$1.9M	Hold	18,054	–	–	0.25%	64
2025 Q3	$1.52M	Hold	18,054	–	–	0.22%	66
2025 Q2	$1.43M	Sell	18,054 -95	-0.5%	-$7.55K	0.21%	67
2025 Q1	$1.63M	Hold	18,149	–	–	0.26%	60
2024 Q4	$1.81M	Hold	18,149	–	–	0.28%	60
2024 Q3	$2.06M	Buy	18,149 +302	+2%	+$35.9K	0.32%	60
2024 Q2	$2.21M	Hold	17,847	–	–	0.37%	60
2024 Q1	$2.35M	Hold	17,847	–	–	0.39%	61
2023 Q4	$1.95M	Hold	17,847	–	–	0.37%	59
2023 Q3	$1.84M	Hold	17,847	–	–	0.39%	60
2023 Q2	$2.06M	Hold	17,847	–	–	0.41%	59
2023 Q1	$1.9M	Buy	17,847 +813	+5%	+$87.8K	0.41%	58
2022 Q4	$1.89M	Hold	17,034	–	–	0.43%	58
2022 Q3	$1.47M	Hold	17,034	–	–	0.36%	63
2022 Q2	$1.55M	Sell	17,034 -260	-2%	-$23.1K	0.36%	62
2022 Q1	$1.42M	Buy	17,294 +260	+2%	+$20.5K	0.28%	67
2021 Q4	$1.31M	Hold	17,034	–	–	0.25%	69
2021 Q3	$1.28M	Hold	17,034	–	–	0.27%	65
2021 Q2	$1.32M	Sell	17,034 -818	-5%	-$60.8K	0.27%	67
2021 Q1	$1.31M	Hold	17,852	–	–	0.29%	64
2020 Q4	$1.39M	Hold	17,852	–	–	0.34%	62
2020 Q3	$1.41M	Sell	17,852 -403	-2%	-$31.6K	0.38%	57
2020 Q2	$1.35M	Buy	18,255 +403	+2%	+$30.3K	0.4%	55
2020 Q1	$1.31M	Buy	17,852 +4,483	+34%	+$352K	0.47%	47
2019 Q4	$1.16M	Sell	13,369 -9	-0.1%	-$739	0.37%	53
2019 Q3	$1.07M	Hold	13,378	–	–	0.37%	50
2019 Q2	$1.07M	Sell	13,378 -44	-0.3%	-$3.37K	0.38%	50
2019 Q1	$1.06M	Buy	13,422 +170	+1%	+$12.7K	0.4%	51
2018 Q4	$966K	Hold	13,252	–	–	0.42%	54
2018 Q3	$897K	Hold	13,252	–	–	0.33%	58
2018 Q2	$768K	Hold	13,252	–	–	0.31%	59
2018 Q1	$689K	Hold	13,252	–	–	0.28%	65
2017 Q4	$712K	Hold	13,252	–	–	0.28%	65
2017 Q3	$810K	Hold	13,252	–	–	0.37%	61
2017 Q2	$810K	Hold	13,252	–	–	0.38%	61
2017 Q1	$803K	Hold	13,252	–	–	0.4%	61
2016 Q4	$744K	Hold	13,252	–	–	0.42%	61
2016 Q3	$789K	Hold	13,252	–	–	0.43%	64
2016 Q2	$728K	Hold	13,252	–	–	0.4%	64
2016 Q1	$669K	Buy	+13,252	New	+$649K	0.4%	65

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Blue Edge Capital's MRK Position: Q1 2026 in Review

Blue Edge Capital increased its Merck (MRK) stake by 4.6% in Q1 2026, buying an estimated $96.6K and bringing the position to 18,891 shares worth $2.27M. The position accounts for 0.3% of the portfolio, ranked #60.

Blue Edge Capital first reported a position in MRK in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.35M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Blue Edge Capital held 18,891 shares of Merck worth $2.27M as of Q1 2026.
Blue Edge Capital bought 837 Merck shares in Q1 2026, an estimated $96.6K.
Merck made up 0.3% of Blue Edge Capital's portfolio in Q1 2026, its #60 holding.
Blue Edge Capital first reported a position in Merck in Q1 2016 and has held it in 41 quarters since.
Blue Edge Capital's Merck position peaked at $2.35M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Blue Edge Capital's 13F filing for Q1 2026, filed 2 Jun 2026.